Ledger.Open graph →
SEC Form D · filed May 7, 2020

Ventus Therapeutics U.S., Inc

Offering
$60.1M
Sold
$16.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NATICK, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Daniel Koerwer · NATICK, MAExecZachary Mcnealy · NATICK, MAExecBrendan Bulik-Sullivan · NATICK, MADirectorMarcelo Bigal · NATICK, MAExec · DirectorJerel Davis · Cleveland, OHDirectorHao Wu · Bellevue, WADirectorJerel Davis · Cleveland, OHDirectorDaniel Koerwer · Cambridge, MAExecHao Wu · Scottsdale, AZDirectorZachary Mcnealy · NATICK, MAExecBrendan Bulik-Sullivan · NATICK, MADirectorMarcelo Bigal · NATICK, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗